Memory impairment correlates with increased S100B serum concentrations in patients with chronic schizophrenia

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 32, Issue 8, 2008, Pages 1789-1792

  Pedersen, Anya ^a   Diedrich, Markus ^a   Kaestner, Florian ^a   Koelkebeck, Katja ^a   Ohrmann, Patricia ^a   Ponath, Gerald ^a   Kipp, Frank ^a   Abel, Simone ^a   Siegmund, Ansgar ^a   Suslow, Thomas ^a   von Eiff, Christof ^a   Arolt, Volker ^a   Rothermundt, Matthias ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Astrocytes; Memory; S100 B; Schizophrenia

Indexed keywords

PROTEIN S100B;

ADULT; ARTICLE; ASTROCYTE; CELL ACTIVATION; COGNITION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; PROTEIN BLOOD LEVEL; SCHIZOPHRENIA; TASK PERFORMANCE; VERBAL MEMORY;

ADULT; CHRONIC DISEASE; FEMALE; HUMANS; MALE; MEMORY DISORDERS; NERVE GROWTH FACTORS; NEUROPSYCHOLOGICAL TESTS; S100 PROTEINS; SCHIZOPHRENIA; VERBAL LEARNING; YOUNG ADULT;

EID: 56449119536     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2008.07.017     Document Type: Article

References (34)

1. Araque A., Parpura V., Sanzgiri R.P., and Haydon P.G. Tripartite synapses: glia, the unacknowledged partner. Trends Neurosci 22 (1999) 208-215
2. Dietrich D.E., Hauser U., Peters M., Zhang Y., Wiesmann M., Hasselmann M., et al. S100B serum levels correlate with target evaluation processing in remitted major depression. Neurosci Lett 354 (2004) 69-73
3. Ehrenreich H., Hinze-Selch D., Stawicki S., Aust C., Knolle-Veentjer S., Wilms S., et al. Improvement of cognitive functions in chronic schizophrenic patients by recombinant human erythropoietin. Mol Psychiatry 12 (2007) 206-220
4. Gromov L.A., Syrovatskaya L.P., and Ovinova G.V. Functional role of the neurospecific S-100 protein in the processes of memory. Neurosci Behav Physiol 22 (1992) 25-39
5. Grosche J., Matyash V., Moeller T., Verkhratsky A., Reichenbach A., and Kettenmann H. Microdomains for neuron-glia interaction: parallel fiber signaling to Bergmann glial cells. Nat Neurosci 2 (1999) 139-143
6. Hanson D.R., and Gottesman I.I. Theories of schizophrenia: a genetic-inflammatory-vascular synthesis. BMC Med Gene 6 (2005) 7
7. Heinrichs R.W., and Zakzanis K.K. Neurocognitive deficit in schizophrenia: a quantitative review of evidence. Neuropsychology 12 (1998) 426-445
8. Hetzel G., Moeller O., Evers S., Erfurth A., Ponath G., Arolt V., et al. The astroglial protein S100B and visually-evoked event-related potentials before and after antidepressant treatment. Psychopharmacology 178 (2005) 161-166
9. Heubrock D. The Auditory-Verbal Learning Test (AVLT) in clinical and experimental neuropsychology: administration, evaluation, and research findings. Z Differ Diagn Psychol 13 (1992) 161-174
10. Kleindienst A., McGinn M.J., Harvey H.B., Colello R.J., Hamm R.J., and Bullock M.R. Enhanced hippocampal neurogenesis by intraventricular S100B infusion is associated with improved cognitive recovery after traumatic brain injury. J Neurotrauma 22 (2005) 645-655
11. Kondziella D., Brenner E., Eyjolfsson E.M., and Sonnewald U. How do glial-neuronal interactions fit into current neurotransmitter hypotheses of schizophrenia?. Neurochem Int 50 (2007) 291-301
12. Lara D.R., Gama C.S., Belmonte-de-Abreu P., Portela L.V.C., Gonçalves C.A., Fonseca M., et al. Increased serum S100B protein in schizophrenia: a study in medication-free patients. J Psychiatr Res 35 (2001) 11-14
13. Mello e Souza T., Rohden A., Meinhardt M., Goncalves C.A., and Quillfeldt J.A. S100B infusion into the rat hippocampus facilitates memory for the inhibitory avoidance task but not for the open-field habituation. Physiol Behav 71 (2000) 29-33
14. Muller N., and Schwarz M. Schizophrenia as an inflammation-mediated dysbalance of glutamatergic neurotransmission. Neurotox Res 10 (2006) 131-148
15. Nygaard O., Langbakk B., and Romner B. Age- and sex-related changes of S-100 protein concentrations in cerebrospinal fluid and serum in patients with no previous history of neurological disorder. Clin Chem 43 (1997) 541-543
16. O'Dowd B.S., Zhao W.Q., Ng K.M., and Robinson S.R. Chicks injected with antisera to either S-100α or S-100β protein develop amnesia for a passive avoidance task. Neurobiol Learn Mem 67 (1997) 197-206
17. Reiber H. Dynamics of brain-derived proteins in cerebrospinal fluid. Clin Chim Acta 310 (2001) 173-186
18. Roder J.K., Roder J.C., and Gerlai R. Conspecific exploration in the T-maze: abnormalities in S100βtransgenic mice. Physiol Behav 60 (1996) 31-36
19. Rothermundt M., Missler U., Arolt V., Peters M., Leadbeater J., Wiesmann M., et al. Increased S100B blood levels in unmedicated and treated schizophrenic patients are correlated with negative symptomatology. Mol Psychiatry 6 (2001) 445-449
20. Rothermundt M., Falkai P., Ponath G., Abel S., Bürkle H., Diedrich M., et al. Glial cell dysfunction in schizophrenia indicated by increased S100B in the CSF. Mol Psychiatry 9 (2004) 897-899
21. Rothermundt M., Ponath G., Glaser T., Hetzel G., and Arolt V. S100B serum levels and long-term improvement of negative symptoms in patients with schizophrenia. Neuropsychopharmacology 29 (2004) 1004-1011
22. Rothermundt M., Ohrmann P., Abel S., Siegmund A., Pedersen A., Ponath G., et al. Glial cell activation in a subgroup of patients with schizophrenia indicated by increased S100B serum concentrations and elevated myo-inositol. Prog Neuro-psychopharmacol Biol Psychiatry 31 (2007) 361-364
23. Sarandol A., Kirli S., Akkaya C., Aysun A., Demirci M., and Sarandol E. Oxidative-antioxidative systems and their relation with serum S100B levels in patients with schizophrenia: effects of short term antipsychotic treatment. Prog Neuro-psychopharmacol Biol Psychiatry 31 (2007) 1164-1169
24. Schmitt A., Bertsch T., Henning U., Tost H., Klimke A., Hennet F.A., et al. Increased serum 100B in elderly, chronic schizophrenic patients: negative correlation with deficit symptoms. Schizophr Res 80 (2005) 305-313
25. Schroeter M.L., Abdul-Khaliq H., Fruhauf S., et al. Serum S100B is increased during early treatment with antipsychotics and in deficit schizophrenia. Schizophr Res 62 (2003) 231-236
26. Steiner J., Bielau H., Bernstein H.G., Bogerts B., and Wunderlich M.T. Increased cerebrospinal fluid and serum levels of S00B in first-onset schizophrenia are not related to a degenerative release of glial fibrillar acidic protein, myelin basic protein and neurone-specific enolase from glia or neurones. J Neurol Neurosurg Psychiatry 77 (2006) 1284-1287
27. Steiner J., Bernstein H.G., Bielau H., Berndt A., Brisch R., Mawrin C., et al. Evidence for a wide extra-astrocytic distribution of S100B in human brain. BMC Neurosci 8 (2007) 2
28. Steiner J., Bernstein H.G., Bielau H., Farkas N., Winter J., Dobrowolny H., et al. S100B-immunopositive glia is elevated in paranoid as compared to residual schizophrenia: a morphometric study. J Psychiatr Res (2007) Nov 12 Electronic publication ahead of print
29. Steiner J., Bernstein H.G., Bogerts B., Gos T., Richter-Landsberg C., Wunderlich M.T., et al. S100B is expressed in, and released from, OLN-93 oligodendrocytes: influence of serum and glucose deprivation. Neuroscience (2008) Apr 8 [Electronic publication ahead of print]
30. Swanson L.W., Teyler T.J., and Thompson R.F. Hippocampal long-term potentiation: mechanisms and implications for memory. Neurosci Res Prog Bull 20 (1982) 613-769
31. Weidlich S., and Lamberti G. DCS. Diagnosticum für Cerebralschädigung (2001), Huber, Bern
32. Whitaker-Azmitia P.M., Wingate M., Borella A., Gerlai R., Roder J., and Azmitia E.C. Transgenic mice overexpressing the neurotrophic factor S-100β show neuronal cytoskeletal and behavioural signs of altered aging processes: implications for Alzheimer's disease and Down's syndrome. Brain Res 776 (1997) 51-60
33. Wiesmann M., Wandinger K.P., Missler U., Eckhoff D., Rothermundt M., Arolt V., et al. Elevated plasma levels of S-100b protein in schizophrenic patients. Biol Psychiatry 45 (1999) 1508-1511
34. Winocur G., Roder J., and Lobaugh N. Learning and memory in S100-β transgenic mice: an analysis of impaired and preserved function. Neurobiol Learn Mem 75 (2001) 230-243